Patents

US 12767721 B2: CD40 antagonist antibody variants with improved pharmacokinetic properties

Granted
2026-10-20
Filed
2021-05-17 application 17999271
Type
Utility · 13 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The disclosure provides variants of an antibody wherein the variant antibodies have modified net charge properties relative to the corresponding unmodified antibody. Certain variants have improved pharmacokinetic properties relative to the corresponding unmodified antibody. Certain antibody variants bind CD40. Compositions and methods of use of the same are also provided.

Source: PTBLXML, file of 2026-10-20 (ipgb20261020.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Bristol-Myers Squibb Company 1,812 patentsUS company or organizationPrinceton, NJBRISTOL MYERS SQUIBB CO SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPTBLXML, file of 2026-10-20

Inventors

InventorPlacePatentsPerson pageSource
Aaron YamniukVancouver, CAPTBLXML, file of 2026-10-20
Mary StruthersPrinceton, NJ13PTBLXML, file of 2026-10-20

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K16/2878PTBLXML, file of 2026-10-20
A61KPreparations for medical, dental or toiletry purposesA61K39/3955PTBLXML, file of 2026-10-20
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P37/06PTBLXML, file of 2026-10-20

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.